Continuous vs intermittent infusion of beta-lactam antibacterial drugs: impact on resistance and outcomes in sepsis - PMWP 170 (2021–2023)

Grant type:
United States Food and Drug Administration
Researchers:
Funded by:
United States Department of Health and Human Services